Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank57
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-21.09
↑ 32% vs avg
Percentile
P57
Within normal range
Streak
3 yr
Consecutive declineElevated
Average
-31.15
Historical baseline
PeriodValueYoY Change
2025-21.09-56.4%
2024-13.49-33.4%
2023-10.11-16.3%
2022-8.70+71.4%
2021-30.40+49.8%
2020-60.59-68.9%
2019-35.87+48.0%
2018-68.99-